FIELD: medicine. SUBSTANCE: method involves determining a set of symptoms describing changes in physiological functions in patients at fixed time intervals and comparing it with reference sets describing standard psychical states, commonly accepted as patterns of human personality properties. Psychical state description at the current period of time is evaluated from the extent the testee properties are represented in the reference sets and the degree they are expressed there. EFFECT: enhanced objectiveness in studying psychic state of patients. 17 dwg , 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE FOR CONTROLLING PSYCHICAL STATE | 1996 |
|
RU2099008C1 |
| METHOD FOR TREATMENT OF AFFECTIVE DISORDERS SELECTED FROM MANIC-DEPRESSIVE PSYCHOSIS, CYCLOTHYMIA, SCHIZOAFFECTIVE PSYCHOSIS AND CAUSED BY EXCESSIVE ALCOHOL CONSUMPTION | 2021 |
|
RU2791700C2 |
| USING ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISEASES, INCREASE NEUROPLASTICITY AND PROMOTE NEUROPROTECTION | 2019 |
|
RU2812786C2 |
| METHOD FOR PREDICTING RECURRENT RISK IN CLINICAL COURSE OF DEPRESSIVE DISORDERS AFTER CARRYING OUT ANTIDEPRESSANT THERAPY | 2004 |
|
RU2266048C2 |
| METHOD FOR DIAGNOSIS OF PSYCHASTHENIA | 2015 |
|
RU2587961C1 |
| METHOD FOR DIAGNOSING ENDOGENOUS PSYCHOSES | 1999 |
|
RU2153290C1 |
| METHOD OF ESTIMATION OF PATIENT'S MENTAL CONDITION WITH ENDOGENIC MENTAL DISORDERS AT THEIR CLINICAL EXAMINATION AND METHOD OF COMPLEX EVALUATION OF THE STATE OF THE IMMUNE SYSTEM OF SUCH PATIENTS | 2016 |
|
RU2648745C1 |
| METHOD FOR DETECTING RISK GROUPS OF MENTAL DISORDERS RELATED TO WORKING PROCESS INTENSITY | 2009 |
|
RU2412645C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD FOR EVALUATION OF MAN PSYCHOPHYSIOLOGICAL STATE | 0 |
|
SU1814875A1 |
